Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.77
WST's Cash to Debt is ranked lower than
59% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. WST: 0.77 )
Ranked among companies with meaningful Cash to Debt only.
WST' s 10-Year Cash to Debt Range
Min: 0.08  Med: 0.26 Max: 0.82
Current: 0.77
0.08
0.82
Equity to Asset 0.60
WST's Equity to Asset is ranked higher than
51% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. WST: 0.60 )
Ranked among companies with meaningful Equity to Asset only.
WST' s 10-Year Equity to Asset Range
Min: 0.35  Med: 0.45 Max: 0.6
Current: 0.6
0.35
0.6
Interest Coverage 10.92
WST's Interest Coverage is ranked lower than
72% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. WST: 10.92 )
Ranked among companies with meaningful Interest Coverage only.
WST' s 10-Year Interest Coverage Range
Min: 3.33  Med: 6.58 Max: 11.05
Current: 10.92
3.33
11.05
F-Score: 6
Z-Score: 5.86
M-Score: -2.73
WACC vs ROIC
9.29%
11.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 12.31
WST's Operating margin (%) is ranked higher than
65% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.56 vs. WST: 12.31 )
Ranked among companies with meaningful Operating margin (%) only.
WST' s 10-Year Operating margin (%) Range
Min: 8.21  Med: 10.93 Max: 14.89
Current: 12.31
8.21
14.89
Net-margin (%) 8.78
WST's Net-margin (%) is ranked higher than
66% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.77 vs. WST: 8.78 )
Ranked among companies with meaningful Net-margin (%) only.
WST' s 10-Year Net-margin (%) Range
Min: -1.33  Med: 6.62 Max: 9.81
Current: 8.78
-1.33
9.81
ROE (%) 12.74
WST's ROE (%) is ranked higher than
72% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. WST: 12.74 )
Ranked among companies with meaningful ROE (%) only.
WST' s 10-Year ROE (%) Range
Min: -2.73  Med: 13.62 Max: 17.79
Current: 12.74
-2.73
17.79
ROA (%) 7.41
WST's ROA (%) is ranked higher than
74% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. WST: 7.41 )
Ranked among companies with meaningful ROA (%) only.
WST' s 10-Year ROA (%) Range
Min: -0.98  Med: 5.61 Max: 9.3
Current: 7.41
-0.98
9.3
ROC (Joel Greenblatt) (%) 20.17
WST's ROC (Joel Greenblatt) (%) is ranked higher than
62% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. WST: 20.17 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WST' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.75  Med: 19.07 Max: 24.79
Current: 20.17
12.75
24.79
Revenue Growth (3Y)(%) 6.60
WST's Revenue Growth (3Y)(%) is ranked higher than
59% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. WST: 6.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WST' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.9  Med: 6.60 Max: 17.8
Current: 6.6
-2.9
17.8
EBITDA Growth (3Y)(%) 14.50
WST's EBITDA Growth (3Y)(%) is ranked higher than
65% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. WST: 14.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WST' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.4  Med: 7.20 Max: 20.2
Current: 14.5
-9.4
20.2
EPS Growth (3Y)(%) 19.70
WST's EPS Growth (3Y)(%) is ranked higher than
72% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. WST: 19.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WST' s 10-Year EPS Growth (3Y)(%) Range
Min: -38.5  Med: 12.80 Max: 57.4
Current: 19.7
-38.5
57.4
» WST's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

WST Guru Trades in Q3 2014

Ron Baron 2,469,096 sh (+37.37%)
RS Investment Management 1,523,476 sh (+9.80%)
Ruane Cunniff 1,028,465 sh (-2.67%)
Ken Fisher 1,266,032 sh (-3.08%)
Jim Simons 1,252,800 sh (-22.05%)
Paul Tudor Jones 11,597 sh (-56.58%)
» More
Q4 2014

WST Guru Trades in Q4 2014

RS Investment Management 2,001,490 sh (+31.38%)
Ken Fisher 1,320,552 sh (+4.31%)
Ron Baron 2,485,135 sh (+0.65%)
Ruane Cunniff 1,024,416 sh (-0.39%)
Jim Simons 940,600 sh (-24.92%)
Paul Tudor Jones 3,800 sh (-67.23%)
» More
Q1 2015

WST Guru Trades in Q1 2015

Ron Baron 2,538,387 sh (+2.14%)
Paul Tudor Jones Sold Out
Ruane Cunniff 1,022,153 sh (-0.22%)
Ken Fisher 1,310,477 sh (-0.76%)
RS Investment Management 1,934,619 sh (-3.34%)
Jim Simons 903,200 sh (-3.98%)
» More
Q2 2015

WST Guru Trades in Q2 2015

Ron Baron 2,543,961 sh (+0.22%)
Ruane Cunniff 1,015,951 sh (-0.61%)
Ken Fisher 1,292,202 sh (-1.39%)
Jim Simons 833,800 sh (-7.68%)
RS Investment Management 1,532,061 sh (-20.81%)
RS Investment Management 1,532,061 sh (-20.81%)
» More
» Details

Insider Trades

Latest Guru Trades with WST

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about West Pharmaceutical Services Inc

Weekly CEO Buys Highlight: WST, PHII, CLMS, CSBK, AMRC
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEO buys is illustrated in the chart below: Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 34.08
WST's P/E(ttm) is ranked lower than
58% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.70 vs. WST: 34.08 )
Ranked among companies with meaningful P/E(ttm) only.
WST' s 10-Year P/E(ttm) Range
Min: 12.43  Med: 22.09 Max: 40.3
Current: 34.08
12.43
40.3
Forward P/E 26.88
WST's Forward P/E is ranked lower than
75% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.41 vs. WST: 26.88 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 33.20
WST's PE(NRI) is ranked lower than
61% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.80 vs. WST: 33.20 )
Ranked among companies with meaningful PE(NRI) only.
WST' s 10-Year PE(NRI) Range
Min: 12.9  Med: 22.26 Max: 36.12
Current: 33.2
12.9
36.12
P/B 4.15
WST's P/B is ranked lower than
62% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. WST: 4.15 )
Ranked among companies with meaningful P/B only.
WST' s 10-Year P/B Range
Min: 1.74  Med: 2.64 Max: 4.46
Current: 4.15
1.74
4.46
P/S 2.98
WST's P/S is ranked lower than
52% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.71 vs. WST: 2.98 )
Ranked among companies with meaningful P/S only.
WST' s 10-Year P/S Range
Min: 1.02  Med: 1.46 Max: 3.19
Current: 2.98
1.02
3.19
PFCF 57.94
WST's PFCF is ranked lower than
77% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.91 vs. WST: 57.94 )
Ranked among companies with meaningful PFCF only.
WST' s 10-Year PFCF Range
Min: 18.37  Med: 40.70 Max: 349.33
Current: 57.94
18.37
349.33
POCF 22.77
WST's POCF is ranked lower than
62% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.50 vs. WST: 22.77 )
Ranked among companies with meaningful POCF only.
WST' s 10-Year POCF Range
Min: 7.56  Med: 11.62 Max: 24.73
Current: 22.77
7.56
24.73
EV-to-EBIT 22.97
WST's EV-to-EBIT is ranked lower than
60% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.94 vs. WST: 22.97 )
Ranked among companies with meaningful EV-to-EBIT only.
WST' s 10-Year EV-to-EBIT Range
Min: 8.2  Med: 17.60 Max: 26.5
Current: 22.97
8.2
26.5
PEG 2.79
WST's PEG is ranked lower than
52% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.71 vs. WST: 2.79 )
Ranked among companies with meaningful PEG only.
WST' s 10-Year PEG Range
Min: 0.77  Med: 1.72 Max: 25.49
Current: 2.79
0.77
25.49
Shiller P/E 42.30
WST's Shiller P/E is ranked lower than
69% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.01 vs. WST: 42.30 )
Ranked among companies with meaningful Shiller P/E only.
WST' s 10-Year Shiller P/E Range
Min: 16.04  Med: 30.07 Max: 61.11
Current: 42.3
16.04
61.11
Current Ratio 2.17
WST's Current Ratio is ranked lower than
55% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. WST: 2.17 )
Ranked among companies with meaningful Current Ratio only.
WST' s 10-Year Current Ratio Range
Min: 1.45  Med: 2.20 Max: 3.1
Current: 2.17
1.45
3.1
Quick Ratio 1.57
WST's Quick Ratio is ranked lower than
51% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. WST: 1.57 )
Ranked among companies with meaningful Quick Ratio only.
WST' s 10-Year Quick Ratio Range
Min: 1.09  Med: 1.57 Max: 2.28
Current: 1.57
1.09
2.28
Days Inventory 70.85
WST's Days Inventory is ranked higher than
83% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. WST: 70.85 )
Ranked among companies with meaningful Days Inventory only.
WST' s 10-Year Days Inventory Range
Min: 45.44  Med: 52.96 Max: 67.18
Current: 70.85
45.44
67.18
Days Sales Outstanding 51.78
WST's Days Sales Outstanding is ranked higher than
69% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.83 vs. WST: 51.78 )
Ranked among companies with meaningful Days Sales Outstanding only.
WST' s 10-Year Days Sales Outstanding Range
Min: 41.76  Med: 49.99 Max: 60.02
Current: 51.78
41.76
60.02

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.77
WST's Dividend Yield is ranked lower than
76% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.46 vs. WST: 0.77 )
Ranked among companies with meaningful Dividend Yield only.
WST' s 10-Year Dividend Yield Range
Min: 0.7  Med: 1.40 Max: 2.16
Current: 0.77
0.7
2.16
Dividend Payout 0.26
WST's Dividend Payout is ranked higher than
70% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. WST: 0.26 )
Ranked among companies with meaningful Dividend Payout only.
WST' s 10-Year Dividend Payout Range
Min: 0.13  Med: 0.30 Max: 2.9
Current: 0.26
0.13
2.9
Dividend growth (3y) 5.90
WST's Dividend growth (3y) is ranked lower than
63% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. WST: 5.90 )
Ranked among companies with meaningful Dividend growth (3y) only.
WST' s 10-Year Dividend growth (3y) Range
Min: 5.2  Med: 6.50 Max: 8.2
Current: 5.9
5.2
8.2
Yield on cost (5-Year) 1.03
WST's Yield on cost (5-Year) is ranked lower than
69% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. WST: 1.03 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
WST' s 10-Year Yield on cost (5-Year) Range
Min: 0.94  Med: 1.87 Max: 2.89
Current: 1.03
0.94
2.89
Share Buyback Rate 0.50
WST's Share Buyback Rate is ranked higher than
83% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. WST: 0.50 )
Ranked among companies with meaningful Share Buyback Rate only.
WST' s 10-Year Share Buyback Rate Range
Min: 4.6  Med: -0.30 Max: -5.5
Current: 0.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 713.63
WST's Price/Net Current Asset Value is ranked lower than
100% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.94 vs. WST: 713.63 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
WST' s 10-Year Price/Net Current Asset Value Range
Min: 726  Med: 726.00 Max: 726
Current: 713.63
Price/Tangible Book 4.86
WST's Price/Tangible Book is ranked lower than
53% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. WST: 4.86 )
Ranked among companies with meaningful Price/Tangible Book only.
WST' s 10-Year Price/Tangible Book Range
Min: 1.73  Med: 3.03 Max: 6.87
Current: 4.86
1.73
6.87
Price/Projected FCF 3.11
WST's Price/Projected FCF is ranked lower than
76% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.73 vs. WST: 3.11 )
Ranked among companies with meaningful Price/Projected FCF only.
WST' s 10-Year Price/Projected FCF Range
Min: 0.97  Med: 2.24 Max: 3.47
Current: 3.11
0.97
3.47
Price/DCF (Earnings Based) 2.46
WST's Price/DCF (Earnings Based) is ranked lower than
74% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.73 vs. WST: 2.46 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 2.05
WST's Price/Median PS Value is ranked lower than
86% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. WST: 2.05 )
Ranked among companies with meaningful Price/Median PS Value only.
WST' s 10-Year Price/Median PS Value Range
Min: 0.47  Med: 0.86 Max: 2.13
Current: 2.05
0.47
2.13
Price/Peter Lynch Fair Value 1.62
WST's Price/Peter Lynch Fair Value is ranked higher than
62% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.99 vs. WST: 1.62 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WST' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.76  Med: 1.65 Max: 76.88
Current: 1.62
0.76
76.88
Price/Graham Number 2.69
WST's Price/Graham Number is ranked lower than
51% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. WST: 2.69 )
Ranked among companies with meaningful Price/Graham Number only.
WST' s 10-Year Price/Graham Number Range
Min: 0.93  Med: 1.70 Max: 3.41
Current: 2.69
0.93
3.41
Earnings Yield (Greenblatt) (%) 4.36
WST's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. WST: 4.36 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WST' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.8  Med: 5.70 Max: 12.2
Current: 4.36
3.8
12.2
Forward Rate of Return (Yacktman) (%) 22.37
WST's Forward Rate of Return (Yacktman) (%) is ranked higher than
79% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.01 vs. WST: 22.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WST' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -4.7  Med: 11.50 Max: 23.4
Current: 22.37
-4.7
23.4

Analyst Estimate

Dec15 Dec16
EPS($) 1.82 2.15
EPS without NRI($) 1.82 2.15

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:BAX, COV, TMO, COO, ISRG » details
Traded in other countries:WPS.Germany,
West Pharmaceutical Services Inc was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923. The Company is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Majority of its business is conducted in healthcare markets. Its reportable segments are Packaging Systems and Delivery Systems. Packaging Systems develops, manufactures and sells primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Delivery Systems develops, manufactures and sells safety and administration systems, multi-component systems for drug administration, and custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. In addition, Delivery Systems is responsible for the continued development and commercialization of the Companys line of proprietary healthcare, administrative and advanced injection systems, including Daikyo CZ, SmartDose and other systems. Packaging Systems has three operating segments: the Americas, Europe and Asia Pacific. The Company competes with several companies across its major product lines. Competition is based mainly on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost control programs across their entire operations. The design, development, manufacturing, marketing and labeling of certain of the Companys products and its customers products that incorporate its products are subject to regulation by governmental authorities in the United States, Europe and other countries, including the FDA and the European Medicines Agency.
» More Articles for WST

Headlines

Articles On GuruFocus.com
West to Host Second Quarter 2015 Conference Call Jul 23 2015 
West Announces Increase to Quarterly Dividend Jul 14 2015 
West Announces Quarterly Dividend Jul 01 2015 
Weekly CEO Buys Highlight: WST, PHII, CLMS, CSBK, AMRC May 26 2015 
West to Present at Upcoming Investor Conferences May 06 2015 
West to Present at Upcoming Investor Conference Jan 09 2015 
CORRECTION - West Announces Quarterly Dividend Dec 22 2014 
DENTSPLY´s Growth Opportunities Dec 16 2014 
West to Host Third Quarter 2014 Conference Call Oct 23 2014 
Is Cooper Companies' Upward Trend Likely to Go On? Mar 25 2014 

More From Other Websites
WEST PHARMACEUTICAL SERVICES INC Financials Aug 08 2015
10-Q for West Pharmaceutical Services, Inc. Aug 05 2015
WEST PHARMACEUTICAL SERVICES INC Files SEC form 10-Q, Quarterly Report Aug 03 2015
Edited Transcript of WST earnings conference call or presentation 30-Jul-15 1:00pm GMT Jul 30 2015
West Pharmaceutical posts 2Q profit Jul 30 2015
West Pharmaceutical posts 2Q profit Jul 30 2015
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 30 2015
West Pharmaceutical Services Inc Earnings Call scheduled for 9:00 am ET today Jul 30 2015
Q2 2015 West Pharmaceutical Services Inc Earnings Release - Before Market Open Jul 30 2015
West Announces Second Quarter 2015 Results Jul 30 2015
West to Host Second Quarter 2015 Conference Call Jul 23 2015
West Expands Manufacturing Capacity at Scottsdale Facility to Support Customer Demand for... Jul 20 2015
West Announces Increase to Quarterly Dividend Jul 14 2015
Advance Auto Parts Set to Join the S&P 500; Jack in the Box, West Pharmaceutical Services to Join... Jul 06 2015
West Announces Quarterly Dividend Jul 01 2015
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jul 01 2015
RS Investment Trades In Its 10 Most Valuable Stakes Jun 23 2015
West Celebrates Groundbreaking of Waterford, Ireland Manufacturing Facility Jun 16 2015
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Jun 03 2015
5 Stocks Insiders Are Buying Right Now May 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK